Lipoprotein(a) is a special type of bad cholesterol that is believed to contribute to heart disease, but there are no approved pharmacological therapies to decrease its concentration in the bloodstream.
Biases in heart disease and metabolic disorder—also known as cardiometabolic—studies are putting the lives of midlife Black and Hispanic women in jeopardy.
A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset chest pain.
For more than four decades, doctors have been split on whether giving steroids during a pediatric open-heart surgery could be helpful for post-operative recovery. A new study is providing a bit more clarity, suggesting there are some benefits for certain kinds of patients.
In a head-to-head comparison of two so-called ‘water pills’ that keep fluid from building up in patients with heart failure, the therapies proved nearly identical in reducing deaths, according to a large study led by Duke Health researchers.
Team members facilitated FaceTime calls and provided comfort care for Nazli Ozkilic’s father, who was in long-term care due to congestive heart failure
مدينة روتشستر، ولاية مينيسوتا -- تزداد مخاطر الإصابة بالخرف والسرطان وأمراض الأوعية الدموية مع التقدم في العمر، وكذا يزداد عدد سكان الولايات المتحدة من كبار السن. لكن العلاقة بين تلك الحالات المرضية ما تزال غير مفهومة بالكامل. في الآونة الأخيرة، أعلن باحثو مايو كلينك عن اكتشاف مثير للاهتمام مفاده: أن وجود تاريخ من الإصابة بالسرطان أو مرض الشريان التاجي قد يقلل من خطر الإصابة بالخرف. ونُشرت نتائج دراستهم في مجلة مرض الزهايمر.
Os riscos de demência, câncer e doença arterial coronariana aumentam com o avanço da idade, e a população dos Estados Unidos está envelhecendo. Mas, até então, a conexão entre as condições não estava plenamente compreendida. Agora, os pesquisadores da Mayo Clinic relatam uma descoberta intrigante: ter histórico de câncer ou doença arterial coronariana pode reduzir o risco de demência. Os resultados do estudo foram publicados na revista médica Journal of Alzheimer's Disease.
Los riesgos de padecer demencia, cáncer y enfermedades vasculares aumentan con la edad, y la población de los EE. UU. está envejeciendo. Sin embargo, no se comprende plenamente la conexión entre las afecciones. Ahora, los investigadores de Mayo Clinic informan un hallazgo interesante: tener antecedentes de cáncer o enfermedad de las arterias coronarias puede reducir el riesgo de padecer demencia. Los resultados del estudio están publicados en la revista Journal of Alzheimer's Disease.
It was the information she couldn’t find that led Amy Kirkham, an assistant professor in the University of Toronto’s Faculty of Kinesiology & Physical Education (KPE), to her latest discovery.
A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center and the University of California San Francisco (UCSF) has discovered the underlying cause of gender differences in immunotherapy-associated myocarditis after immune checkpoint inhibitor (ICI) treatment. Their findings point to possible treatment strategies for this side effect, which disproportionately affects female patients.
In the past several years, myocarditis has been of public interest because of cases associated with vaccines for SARS-CoV2 or related conditions. Another form of myocarditis has been linked to immune checkpoint inhibitors (ICIs) used in cancer care. ICI-induced myocarditis is a potentially fatal side effect of ICI usage, and it appears that the adverse cardiac effects may disproportionally impact female patients. This finding is in contrast to other forms of myocarditis, with more cases reported in male patients.
Adults with hypertension saw a small, but consequential, rise in their blood pressure levels during the first eight months of the COVID-19 pandemic, while the number of times they had their blood pressure measured dropped significantly, according to a study supported by the National Institutes of Health.
Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai are presenting an array of innovative research data and leading discussions on medical breakthroughs during the American Heart Association (AHA) Scientific Sessions, taking place in Chicago, Nov. 5-7.
A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination.
New research published in the Journal of the American College of Cardiology shows the use of drug-coated balloons is an optimal approach compared to bare metal stents in treating femoropopliteal lesions.
Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled clinical tools have to be easily available and used.
The destruction of red blood cells, or mechanical hemolysis, is an inevitable complication of interventional devices, so scientists want to gain a better understanding of the phenomenon. In Physics of Fluids, researchers develop a red blood cell destruction model based on simulations of dissipative particle dynamics within a high shear flow. The team discovered that acceleration during shearing is a major factor in red blood cell destruction, beyond exposure time and shear stress. They recommend adding a flow buffer structure to the structural design of ventricular assist devices to reduce part of the hemolysis caused by shear acceleration.
MIM Software Inc., a leading global provider of medical imaging software, announced today it has received approval from Health Canada for its AI auto-contouring solution, Contour ProtégéAI™.
A large-scale comparison of direct oral anticoagulants (blood thinners), commonly prescribed for irregular heartbeats, has identified the drug with the lowest risk of bleeding, in a new study led by UCL researchers.
U.S. deaths from heart disease spiked in 2020 at the start of the COVID-19 pandemic after a steady decline from 2010 to 2019, reversing a public health success, according to preliminary research to be presented at the American Heart Association’s Scientific Sessions 2022.
RUDN doctors have found genetic factors that increase the risk of recurrent vascular stenosis after stent placement. The data obtained will help to adjust the treatment and choose an individual approach for patients with coronary heart disease.
Two minute bursts of vigorous activity totalling 15 minutes a week are associated with a reduced risk of death, according to research published today in European Heart Journal, a journal of the European Society of Cardiology (ESC).1
Ahead of World Stroke Day, Oct. 29, investigators from the Department of Neurology at Cedars-Sinai have new information on stroke-related health disparities.
In acknowledgment of her research advancing the field of cardiovascular science, UTHealth Houston’s Louise McCullough, MD, PhD, has been honored with the 2022 American Heart Association Basic Research Prize.
Elite young athletes are set to benefit from a novel screening tool with the potential to change clinical practice by ruling out a serious heart condition frequently misdiagnosed.
A global study of over 28,000 people has provided the strongest evidence to date that lowering blood pressure in later life can cut the risk of dementia.
Thousands of people have new hope for treatment of thoracic aortic arch disease and UH Harrington Heart & Vascular Institute is at the forefront of studying the safety and efficacy of this new procedure.
Chronic heart failure causes the cell’s powerhouses to dysfunction, in part due to overconsumption of an important intermediary compound in energy production.
Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage.
New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks rose significantly during pandemic surges, including the COVID-19 Omicron surges, overall reversing a heart-healthier pre-pandemic trend.
The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as director of the Vascular Surgery Fellowship Program. Baril, who joined Cedars-Sinai in 2020, aims to advance the academic medical center’s excellence in vascular care, research and education for current and future fellows.
Quando falamos em AVCs, cada segundo é importante. Especialistas da Mayo Clinic explicam como reconhecer os sinais de um AVC e como reduzir o seu risco. “Dizemos com frequência que o ‘tempo é valioso para o cérebro,’ o que significa que, quanto mais rápido for restabelecido o fluxo sanguíneo para ele, melhores serão os resultados para o paciente,” afirma o Dr. James Meschia, neurologista da Mayo Clinic, na Flórida.
مدينة روتشستر، ولاية مينيسوتا. — كل ثانية مهمة عند الحديث عن السكتات الدماغية. حيث يشرح أحد خبراء مايو كلينك كيفية التعرف على مؤشرات السَّكتة الدماغية وكيفية التقليل من مخاطر حدوثها.
"نحن نقول دائمًا إن (الوقت من ذهب)، أي أنه كلما أسرعنا في استعادة تدفق الدم إلى الدماغ، صارت النتائج أفضل بالنسبة للمريض" - كما يقول جيمس ميسكيا، دكتور الطب، طبيب الأعصاب في مايو كلينك في فلوريدا.
A mouse study by Kristin Stanford, a physiology and cell biology researcher with The Ohio State University College of Medicine at the Wexner Medical Center, provides new ways to determine how maternal and paternal exercise improve metabolic health of offspring.
Cuando se trata de accidentes cerebrovasculares , cada segundo cuenta. Los expertos de Mayo Clinic explican cómo reconocer los signos de un accidente cerebrovascular y cómo reducir el riesgo de que se produzcan. "A menudo decimos 'el tiempo es cerebro' para referirnos a que cuanto antes podamos restaurar el flujo de sangre al cerebro, mejores serán los resultados para el paciente," dice el Dr. James Meschia, neurólogo de Mayo Clinic en Florida .
Researchers at Columbia University Mailman School of Public Health evaluated an expanded measure of cardiovascular health (CVH) that includes sleep as an eighth metric, in relation to cardiovascular disease risk.
For decades, scientists in Berlin have been researching a strange hereditary condition that results in half the members of certain families having unusually short fingers and extremely high blood pressure.